Ieq Capital »

Protalix Biotherapeutics shares owned by Ieq Capital

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Ieq Capital from 13F filings

Historical chart of Ieq Capital investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Ieq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Ieq Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $32k 14k 2.33

More positions owned by Ieq Capital

NVIDIA Corporation (NVDA)
Roblox Corp Cl A (RBLX)
Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Meta Platforms Cl A (META)
Crowdstrike Hldgs Cl A (CRWD)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust St Str Blo 1 Etf (BIL)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Ieq Capital

Top funds holding Protalix Biotherapeutics

BlackRock
Renaissance Technologies
Geode Capital Management
State Street Corporation
Northern Trust
Vanguard Portfolio Management
Stratos Wealth Partners
Dimensional Fund Advisors
Goldman Sachs Group
Marshall Wace
Citadel Advisors
Susquehanna International
Morgan Stanley
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Bank of New York Mellon

View all funds holding Protalix Biotherapeutics